Can a tailored Plant-Based formula tame viral respiratory infections?
NCT ID NCT07805447
First seen Sep 04, 2026 · Last updated Sep 04, 2026
Summary
This Phase 1 trial tests a personalized approach to treating acute viral respiratory infections using a platform called Dynamic Pathology-Based Therapy (DPBT). Researchers use a predefined algorithm to match each adult participant's specific inflammatory state with a botanical formulation module, such as PurInf I, which may be given alone or in combination. The study enrolls about 30 adults aged 18 to 80 and aims to assess the safety, tolerability, and feasibility of this approach over about 7 to 10 days of treatment, with follow-up through Day 12. The focus is on whether the protocol can be implemented smoothly and whether the treatment is well-tolerated, not on proving effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- PurInf I botanical formulation, a proprietary oral multi-ingredient botanical product selected by a predefined algorithm based on the participant's pathological state
- What this could lead to
- If successful, this could lead to a personalized, plant-based treatment approach for viral respiratory infections that adapts to each person's specific symptoms and recovery.
- What could go wrong
- This is an early Phase 1 study with only 30 participants, so it focuses on safety and feasibility, not effectiveness. The botanical formulation may not prove beneficial, and side effects or tolerability issues could arise.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1
The first testing in people. Mainly checks safety and dose, usually in a small group.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2027
An estimate. Start dates often move.
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria * Adults aged 18-80 years. * Presence of an acute viral respiratory infection or clinical presentation consistent with an acute viral respiratory infection. * Onset of acute respiratory symptoms within a predefined period before enrollment. * Presence of one or more predefined pathological states eligible for treatment according to the DPBT clinical algorithm. * Able and willing to comply with study treatment, clinical assessments, and viral testing. * Able to understand the study requirements and provide written informed consent. Exclusion Criteria * Severe or life-threatening illness requiring immediate hospitalization or emergency medical treatment at enrollment. * Known allergy, hypersensitivity, or clinically significant intolerance to any ingredient in the botanical formulations that may be administered. * Pregnancy or breastfeeding. * Significant medical condition that, in the investigator's judgment, would make participation unsafe or interfere with interpretation of study outcomes. * Current participation in another interventional clinical trial that could interfere with this study. * Unable or unwilling to comply with study procedures or provide informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute viral respiratory infection are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
All Natural Medicine Clinic, LLC
Rockville, Maryland, 20852, United States